Can OK lenses and atropine actually be used? These myopia management measures are very important, as the degree of myopia in children increases dramatically. Atropine | Children | OK lenses

Release time:Apr 13, 2024 20:45 PM

During the three years of the epidemic, most school-age children have taken many online classes, and the pediatric ophthalmology clinic has experienced a continuous peak of visits. Even on Saturdays, it is necessary to receive up to 600 patients for outpatient visits. The outpatient appointment on Saturdays often needs to be scheduled one month in advance. A large number of children who requested eye examinations crowded the outpatient department, and the scene continued to demand extra signs. The inspection team surrounded the hall and even lined up at the elevator entrance. After the examination, many children wore small glasses. But we also found that many children who started controlling myopia before the epidemic have achieved good results.

Xixi is one of them. He is already 12 years old this year. Three years ago, during a school physical examination, it was found that he had 100 degrees myopia. His mother noticed that he occasionally squinted his eyes. When examining Xixi at that time, it was found that although he was only 100 degrees myopic, the child's corneal curvature was particularly flat, and the corresponding eye axis was very long, about 25.50 millimeters.

What is this concept? We know that the axial length of highly myopic eyes is over 26.5 millimeters. That is to say, there is still 1 millimeter of room for Xixi's eye axis to reach the category of highly myopic eye axis. Once the value of high myopia axis is reached and exceeded, even in adulthood, the degree of myopia in children will continue to increase, ultimately leading to high myopia fundus lesions.

Therefore, although Xi Xi's myopia is not high at this stage, I still matched him with a corneal shaping lens, and gave him a joint scheme of low concentration atropine with a corneal shaping lens every night. In the subsequent follow-up examination, both visual acuity and axial control achieved ideal results. Over the past three years, Xixi has undergone a large number of online courses, but the effect of myopia control is still very ideal, with an annual growth rate controlled within 25 degrees. I believe that there must be many children who benefit from the protection of corneal reshaping lenses during the pandemic.

Xi Xi has been wearing corneal reshaping lenses since the early stages of the pandemic in June 2020. During the pandemic, she has undergone a large number of online classes, and due to the dual protection of corneal reshaping lenses and low concentration atropine eye drops, her myopia has been effectively controlled without outdoor exercise.

What is a corneal reshaping lens? How does it control the growth of myopia? Is your child suitable for wearing corneal shaping glasses?

Corneal reshaping lens is a rigid corneal contact lens designed in inverse geometry. Unlike traditional contact lenses, it is worn at night and removed during the day. Shaping principle: After a night of pressure from the lens, the corneal shape is reshaped, making the center of the cornea flatter and the periphery of the cornea steeper. Multiple studies have shown that corneal reshaping lenses can delay the progression of myopia by 35% to 80%, making them the most effective optical correction method for controlling myopia.

Corneal reshaping lenses, also known as "OK lenses", are suitable for children over 8 years old with rapid progression of myopia, as well as children with strabismus with myopia degree below 500 degrees, astigmatism below 250 degrees, and no obvious ocular surface diseases. Its advantages are good myopia control effect, no need to wear glasses during the day, which can meet the needs of children's sports, learning, and daily life. The disadvantage is that it is expensive, needs to be used under adult supervision, and requires lens care and frequent re examination. It should be noted that OK lenses belong to Class III medical devices and must be matched by ophthalmologists and optometrists in formal medical institutions.

Low concentration atropine was once known as a "miracle drug," but where is it? Parents have mixed opinions on low concentration atropine.

Low concentration atropine can delay the progression of myopia to a certain extent and is one of the most cost-effective methods for controlling myopia progression, which is simple and effective. Its mechanism of action is to increase the blood supply to the fundus choroid and delay the growth of myopia. The myopia control effect and side effects of atropine are concentration dependent. Therefore, in order to balance efficacy and safety, the academic community has been exploring its appropriate concentration. A 5-year ATOM study conducted in Singapore showed that 0.01% atropine eye drops have a good effect on delaying the progression of myopia, and compared with high concentration atropine eye drops, they have the smallest adverse reactions and the smallest rebound effect after discontinuation, with a myopia delay effect of about 50%. Similar studies have also pointed out that the myopia prevention and control effect of 0.01% atropine eye drops can reach 27% to 46%. This control effect is very meaningful for controlling myopia itself and reducing complications of high myopia.

At present, the most commonly used concentration of atropine in clinical practice for the treatment or control of myopia is 0.01%, which has the least side effects and definite therapeutic effects. Therefore, for children with poor efficacy of 0.01% atropine eye drops, it may be considered to increase the drug concentration or increase the frequency of medication administration. But the problem also arises: as the efficacy improves, side effects will become more prominent, and symptoms of photophobia and blurred vision will become more pronounced. In addition, about 10% of children do not respond to atropine, so not every child who uses low concentration atropine eye drops is effective.

Children with myopia that has increased by more than 75 degrees in a year, or those with initial myopia less than 9 years old, may consider using low concentration atropine eye drops. Use once before bedtime every night, usually continuously for 2 to 3 years. Current guidelines suggest that low concentration atropine can be used continuously until the end of puberty.

However, before using atropine eye drops, it is necessary to determine whether the child's basic development rate of myopia is fast or slow, because once atropine is started, it needs to be used continuously for 2 years. Even if the medication is stopped, it needs to be reduced in dosage, such as taking it every other day until it is stopped. Therefore, it is necessary to undergo professional ophthalmic and refractive examinations. Doctors can objectively judge the basic development speed of myopia in children, inform them of possible control effects, and provide different myopia prevention and control plans. If the child's myopia progression is not rapid and does not increase by more than 50 degrees per year, there is no need to take atropine eye drops; If the child's myopia increases by 75 degrees or more in one year, low concentration atropine eye drops can be considered; If the child experiences an increase of 200 degrees of myopia per year, a combination therapy is needed to control myopia, such as low concentration atropine eye drops combined with corneal reshaping lenses, multifocal soft lenses, or defocus frame glasses.

It should be noted that it is not recommended for children who suffer from glaucoma or have a tendency towards glaucoma, are allergic to scopolamine alkaloids, or have brain trauma. The advantage of low concentration atropine eye drops is that they are easy to use, but the disadvantage is that although they can be used to control the progression of myopia, children with myopia still need to wear frame glasses or OK glasses to meet their daily eye needs. The main adverse reactions are photophobia, insufficient close range regulation, and allergic reactions to the eyelids and conjunctiva.

It can be said that myopia prevention and control focus on correct cognition and long-term persistence. Once a child's true myopia is formed, it cannot be reversed. When the degree of myopia increases by more than 75 degrees per year, it indicates that the child's myopia is progressing rapidly and should be taken seriously. As children return to campus, coupled with sufficient outdoor activities, less exposure to electronic screens, more distance viewing, and reduced continuous close range eye use, myopia can be prevented and controlled. In addition, it is important to eat less sweet and fried foods, as these foods can affect calcium absorption, leading to increased axial length and myopia. Try not to let children develop high myopia, otherwise it can cause many complications in the eyes, leading to irreversible damage to vision.

Why is "Cancer King" immunotherapy ineffective? Fudan Cancer Hospital Reveals New Mechanisms of Immunosuppressive Environment for pancreatic cancer CRIP1 | Tumor | pancreatic cancer
Why is "Cancer King" immunotherapy ineffective? Fudan Cancer Hospital Reveals New Mechanisms of Immunosuppressive Environment for pancreatic cancer CRIP1 | Tumor | pancreatic cancer

Immunotherapy has been proven to achieve significant therapeutic effects in various solid tumors. However, for pancreatic cancer, known as the "king of cancer", immunotherapy has been ineffective. On August 4, Professor Yu Xianjun, Dean of the Cancer Hospital Affiliated to Fudan University, and Shi Si, Associate Professor of Pancreatic Surgery released a research achievement, which first found the key role of cysteine rich protein 1 in shaping the immunosuppressive microenvironment of pancreatic cancer, filled the gap in the research field of immunosuppressive microenvironment of pancreatic cancer, and provided a theoretical basis for precise immunotherapy of pancreatic cancer patients. Ductal adenocarcinoma of the pancreas is the main type of pancreatic cancer, accounting for about 90% of all pancreatic cancer. Due to its high malignancy and poor treatment effectiveness, pancreatic ductal adenocarcinoma has always been one of the most malignant tumors. In recent years, the level of surgical techniques and comprehensive treatment has been achieved

A 14-year-old girl suffers from a rare eye disease and receives support from a public welfare fund. Symptoms of "I haven't looked in the mirror for a long time" | Patient | Public welfare
A 14-year-old girl suffers from a rare eye disease and receives support from a public welfare fund. Symptoms of "I haven't looked in the mirror for a long time" | Patient | Public welfare

A 14-year-old girl has been experiencing symptoms such as protruding pupils, incomplete eye closure, corneal injury, restricted eye movement, and overall fatigue for several years. The physical discomfort and facial abnormalities caused by eye diseases have made her increasingly reticent, and her temperament is vastly different from before. At the Ophthalmology Department of the Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, the pupil has been diagnosed with a rare thyroid ophthalmopathy combined with myasthenia gravis, which requires prompt treatment. However, considering the young age of the pupil, conventional hormone and radiation therapy cannot be used. Therefore, Zhou Huifang, Deputy Director of Ophthalmology and thyroid ophthalmology expert, has developed a targeted drug combined with surgical treatment plan for it, and targeted drug treatment will be performed first. Three months ago, I was hospitalized for one week with mydriasis and received intravenous targeted drug treatment. Afterwards, I went home for observation and followed up on time

The municipal eye disease prevention and treatment center launched the dry eye diagnosis and treatment studio, and the incidence rate of dry eye in China is about 21% to 30% of the meibomian gland | dry eye | eye disease
The municipal eye disease prevention and treatment center launched the dry eye diagnosis and treatment studio, and the incidence rate of dry eye in China is about 21% to 30% of the meibomian gland | dry eye | eye disease

According to the Statistics of Chinese Dry Eye Expert Consensus, the incidence rate of dry eye in China is about 21%~30%, and it is estimated that there are at least 300 million patients nationwide. The Dry Eye Diagnosis and Treatment Studio of Shanghai Eye Disease Prevention and Treatment Center was officially launched today. In the future, the studio will continuously improve the dry eye diagnosis and treatment standards, and form standardized diagnosis and treatment concepts and service models. Suitable technologies will be promoted to the community, allowing residents to enjoy convenient dry eye diagnosis and treatment services at their doorstep. Executive Dean and Party Secretary Gao Wei stated that this is also one of the livelihood service measures recently launched by the hospital around high-quality development and meeting the needs of the people. It is reported that dry eye syndrome is a chronic ocular surface disease caused by multiple factors. The instability of the tear film or imbalance of the ocular surface microenvironment caused by abnormal quality, quantity, and dynamics of tears can be accompanied by ocular surface inflammatory reactions, tissue damage, and nerve abnormalities, resulting in various discomforts in the eyes

The Ninth Hospital has taken the lead in formulating the world's first consensus on core indicators for clinical evaluation of dental implants, which has been officially published in clinical practice
The Ninth Hospital has taken the lead in formulating the world's first consensus on core indicators for clinical evaluation of dental implants, which has been officially published in clinical practice

The International Dental Implant Consensus Report, jointly written by the Ninth People's Hospital affiliated with Shanghai Jiao Tong University School of Medicine and renowned universities in the field of dentistry such as Harvard University, University of Zurich, University of Gothenburg, Columbia University, and University of Frankfurt, has recently been jointly published in top journals in the field of dentistry, including Clinical Periodontology and Clinical Dental Implant Research. This consensus has for the first time established an internationally unified core set of indicators for evaluating the clinical effectiveness of dental implants, covering the five key areas of the field of dental implants. It is of milestone significance for carrying out standardized clinical diagnosis, treatment, and research on dental implants. The core evaluation indicators determined by this consensus will become an important benchmark for scholars in the field of dental implants worldwide to conduct high-quality research. The consensus is composed of 8 top international experts in the field of oral implantation

Recently, autologous hematopoietic stem cell therapy was completed in Shanghai, and British girls born in the 1990s have suffered from multiple relapses of blood diseases, including stem cells, peripheral blood, and diseases
Recently, autologous hematopoietic stem cell therapy was completed in Shanghai, and British girls born in the 1990s have suffered from multiple relapses of blood diseases, including stem cells, peripheral blood, and diseases

Recently, Catherine, a British girl born in the 1990s, received autologous peripheral blood hematopoietic stem cell transfusion at the Cancer Center of Shanghai Jiahui International Hospital, and was successfully discharged from the warehouse. She is now on her way back to China after being discharged from the hospital. She is also the first patient at Shanghai Jiahui International Hospital to complete relevant treatments. In 2019, Catherine was diagnosed with Hodgkin's lymphoma in the UK, and after treatment, the disease completely improved. During her work and life in China in 2021, she went to seek medical attention due to multiple enlarged lymph nodes. Pathological biopsy confirmed a recurrence of Hodgkin's lymphoma, and through combined targeted drug treatment, her condition was temporarily under control. Last year in the second half of the year, when the disease recurred, the girl began to use immunotherapy combined with targeted drugs for treatment. Expert evaluation suggests that for young patients with hematological tumors, the risk of recurrence is high and treatment difficulty is increasing in the future. Autologous hematopoietic stem cell therapy is recommended